We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$2.65B
AUM Growth
-$120M
Cap. Flow
-$673K
Cap. Flow %
-0.03%
Top 10 Hldgs %
39.69%
Holding
444
New
21
Increased
84
Reduced
61
Closed
28

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$31.1M
2
LW icon
Lamb Weston
LW
+$29.3M
3
META icon
Meta Platforms (Facebook)
META
+$21M
4
UNH icon
UnitedHealth
UNH
+$10.6M
5
HDB icon
HDFC Bank
HDB
+$8.44M

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$37.8M
2
HOLX
Hologic
HOLX
+$27.6M
3
EW icon
Edwards Lifesciences
EW
+$26.2M
4
ABT icon
Abbott
ABT
+$8.59M
5
AMD icon
Advanced Micro Devices
AMD
+$8.42M

Sector Composition

Rank Sector Weight
1 Technology 31.23%
2 Healthcare 15.05%
3 Financials 14.66%
4 Consumer Discretionary 12.23%
5 Communication Services 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
76
Elevance Health
ELV
$86.2B
$4.75M 0.18%
10,900
MS icon
77
Morgan Stanley
MS
$338B
$4.7M 0.18%
57,526
TJX icon
78
TJX Companies
TJX
$175B
$4.65M 0.18%
52,300
CERT icon
79
Certara
CERT
$1.23B
$4.52M 0.17%
310,600
+61,400
+25% +$1.03M
ADP icon
80
Automatic Data Processing
ADP
$109B
$4.48M 0.17%
18,619
-400
-2% -$97.5K
MRSH
81
Marsh
MRSH
$91B
$4.34M 0.16%
22,824
+500
+2% +$95.8K
AXP icon
82
American Express
AXP
$229B
$4.33M 0.16%
29,000
+100
+0.3% +$16.4K
GILD icon
83
Gilead Sciences
GILD
$165B
$4.32M 0.16%
57,700
SYK icon
84
Stryker
SYK
$133B
$4.29M 0.16%
15,700
+400
+3% +$115K
VRTX icon
85
Vertex Pharmaceuticals
VRTX
$133B
$4.14M 0.16%
+11,900
New +$4.16M
CVS icon
86
CVS Health
CVS
$122B
$4.03M 0.15%
57,700
-1,700
-3% -$120K
CI icon
87
Cigna
CI
$73.6B
$3.92M 0.15%
13,715
LRCX icon
88
Lam Research
LRCX
$383B
$3.92M 0.15%
62,500
PGR icon
89
Progressive
PGR
$124B
$3.72M 0.14%
26,700
+700
+3% +$92.1K
C icon
90
Citigroup
C
$227B
$3.69M 0.14%
89,800
ZTS icon
91
Zoetis
ZTS
$30.9B
$3.69M 0.14%
21,200
AMT icon
92
American Tower
AMT
$78.8B
$3.51M 0.13%
21,350
TMUS icon
93
T-Mobile US
TMUS
$191B
$3.46M 0.13%
24,700
-3,300
-12% -$457K
ATVI
94
DELISTED
Activision Blizzard
ATVI
$3.39M 0.13%
36,200
+2,100
+6% +$192K
BDX icon
95
Becton Dickinson
BDX
$48.9B
$3.39M 0.13%
13,100
+400
+3% +$108K
MU icon
96
Micron Technology
MU
$972B
$3.37M 0.13%
49,600
PANW icon
97
Palo Alto Networks
PANW
$314B
$3.31M 0.12%
28,200
+1,000
+4% +$118K
FISV
98
Fiserv Inc
FISV
$27.8B
$3.24M 0.12%
28,700
+18,400
+179% +$2.27M
YUMC icon
99
Yum China
YUMC
$16.5B
$3.23M 0.12%
58,000
-2,400
-4% -$134K
SNPS icon
100
Synopsys
SNPS
$78.8B
$3.21M 0.12%
7,000

Similar funds

E. Ohman J:or Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, E. Ohman J:or Asset Management held 444 positions worth $2.65B, down 4.3% from $2.77B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

E. Ohman J:or Asset Management's Q3 2023 filing shows 21 new, 84 increased, 61 reduced and 28 closed positions. Its largest new stake was Meta Platforms (Facebook): 69,800 shares worth $21M. The largest sale was Colgate-Palmolive, an estimated $37.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • E. Ohman J:or Asset Management's largest Q3 2023 buy was Meta Platforms (Facebook): 69,800 shares worth $21M.
  • E. Ohman J:or Asset Management added most to Boston Scientific in Q3 2023, an estimated $31.1M increase.
  • E. Ohman J:or Asset Management's biggest Q3 2023 reduction was Colgate-Palmolive, cutting an estimated $37.8M.
  • E. Ohman J:or Asset Management fully exited Abbott in Q3 2023, selling an estimated $8.59M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 40% of its $2.65B portfolio in Q3 2023.
  • E. Ohman J:or Asset Management opened 21 new positions and closed 28 in Q3 2023.
  • E. Ohman J:or Asset Management's portfolio value fell 4.3% quarter-over-quarter to $2.65B.

Based on E. Ohman J:or Asset Management's 13F filing for Q3 2023, filed 6 Feb 2024.